Larvol Delta - Annovis-Bio-Announces-Issuance-of-US-Patent-Covering-the-Use-of-Lead-Drug-Candidate-Buntanetap-for-Prevention-or-Treatment-of-Disease-States-Due-to-Metal-DisHomeostasis-in-Healthy-or-Sick-Humans

Posiphen (buntanetap) - Annovis Bio

https://www.globenewswire.com/news-release/2023/04/27/2656131/0/en/Annovis-Bio-Announces-Issuance-of-U-S-Patent-Covering-the-Use-of-Lead-Drug-Candidate-Buntanetap-for-Prevention-or-Treatment-of-Disease-States-Due-to-Metal-Dis-Homeostasis-in-Health.html

Apr 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next